Genticel Company

Gentiel develops therapeutic vaccines for the prevention of cervical cancer in HPV infected women.

Investors

Total Funding: $41 382 652
Founded Date: 2001-01-01
Headquarters: Paris, Ile-de-France, France
Last Funding Type: Series D
Last Funding Date: 2013-04-24
Industry: Longevity
Funding Status: M&A
Register and Claim Ownership